Public Health Impact of the MVA-BN Vaccine During the 2022 Mpox Outbreak: A Systematic Review
Background/Objectives: Previously endemic to sub-Saharan Africa, mpox has since emerged globally, resulting in more than 150,000 cases in over 100 countries in the 2022 outbreak. The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is licensed and recommended for at-risk populations in many...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2025-10-01
|
| Serija: | Infectious Disease Reports |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2036-7449/17/5/124 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|